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ABSTRACT

A sensor comprising a membrane containing bacteriorhodop
sin. In one embodiment, the sensor comprises a layer of
purple membrane between a first and a second electrode,
wherein the electrodes are connected to a circuit such that a
signal is produced when a charge is transferred across the
membrane. In another embodiment, the sensor comprises a
field effect transistor with a layer of purple membrane depos
ited on the gate. The layer of purple membrane may be further
functionalized by adding fluorophores to the layer o f purple
membrane. The fluorophores may be deposited adjacent to
the layer of purple membrane, or the fluorophores may be
attached to the layer of purple membrane with linkages. The
fluorophores or linkages between the fluorophores and the
purple membrane may be functionalized with receptors to
produce sensors for targeted chemical or biological species.
11 Claims, 15 Drawing Sheets
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BACTERIORHODOPSIN-BASED SENSORS

SUMMARY OF THE INVENTION

RELATED APPLICATIONS

In one embodiment, the invention provides a sensor com
prising a membrane layer, containing bacteriorhodopsin, two
electrodes, a substrate and a circuit. The membrane layer is
arranged between the electrodes, the electrodes being adja
cent to the circuit such that the circuit produces a signal when
charge is transferred through the membrane between elec
trodes. When the membrane is exposed to visible light, a
charge is transferred through the membrane, thus generating
a signal in the circuit. The sensor may achieve additional
functionality with the inclusion of fluorophores in proximity
to the membrane. The fluorophores can absorb light and then
transfer the energy of the light to the bacteriorhodopsin via
radiative or non-radiative eneigy transfer. The fluorophores
are optionally quantum dots which may be further function
alized to modify the response of the sensor to particular
stimuli, such as targeted chemicals or biological species. A
plurality of sensors according to this embodiment may be
arranged to produce a chemical or biological sensor with
multiple sensitivities.
In another embodiment, the invention provides a sensor
comprising a semiconductor transistor having a drain, a
source, and a gate, and an adhesion spacer layer adjacent to
the gate. A membrane layer, containing bacteriorhodopsin, is
adjacent to the adhesion spacer layer. The semiconductor
transistor is operatively connected to a circuit such that a
change in the gate potential will produce a signal in the
circuit. When the membrane is exposed to visible light, the
potential at the gate of the transistor changes resulting in a
signal in the circuit. The sensor may achieve additional func
tionality with the attachment of fluorophores to the mem
brane. The fluorophores can absorb light and then transfer the
energy of the light to the bacteriorhodopsin via radiative or
non-radiative energy transfer. The fluorophores are option
ally quantum dots which may be further functionalized to
modify the response of the sensor to particular stimuli, such
as targeted chemicals or biological species. A plurality of
sensors according to this embodiment may be arranged to
produce a chemical or biological sensor with multiple sensi
tivities.
In another embodiment, the invention provides a sensor
comprising a semiconductor transistor having a drain, a
source, and a gate, and a membrane layer, containing bacte
riorhodopsin, adjacent to the gate. The semiconductor tran
sistor is operatively connected to a circuit such that a change
in the gate potential will produce a signal in the circuit. When
the membrane is exposed to visible light, the potential at the
gate of the transistor changes resulting in a signal in the
circuit. The sensor may achieve additional functionality with
the attachment of fluorophores to the membrane. The fluoro
phores can absorb light and then transfer the energy of the
light to the bacteriorhodopsin via radiative or non-radiative
energy transfer. The fluorophores are optionally quantum
dots which may be further functionalized to modify the
response of the sensor to particular stimuli, such as targeted
chemicals or biological species. A plurality of sensors accord
ing to this embodiment may be arranged to produce a chemi
cal or biological sensor with multiple sensitivities.
In another embodiment, the invention provides a method
for detecting targeted chemical or biological species in a
sample using a bacteriorhodopsin-based sensor according to
the invention. The method comprises observing a first signal
from a bacteriorhodopsin-based sensor with functionalized
fluorophores, in the presence of light with a wavelength
shorter than 570 nm, contacting the sensor with a sample,
observing a second signal from the sensor, in the presence of

This application claims priority to U.S. Provisional Patent
Application Ser. No. 60/991,060, filed Nov. 29, 2007, which
is incorporated by reference in its entirety.
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This invention was made with U.S. Government support
under Grant No. DAAD17-03-C-0125 awarded by the United
States Army. The U.S. Government has certain rights in the
invention.
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BACKGROUND
Bacteriorhodopsin (bR) is a retinal protein that has been
intensely studied over the years due to its inherent ability to
function as a light-driven proton pump. It is composed of a
248 amino acidpeptide with a molecular weight o f26,784 Da
and it possesses a covalently attached retinal group. Structur
ally similar to the visual rhodopsin found in the human eye,
bacteriorhodopsin is found in the cell membrane of Halobacterium salinarium where it functions to establish a proton and
electrochemical gradient for the synthesis of ATP under
anaerobic/light conditions. Hampp, Chem. Rev., 100 (5),
1755-76 (2000). Upon illumination with yellow-green light, a
proton is pumped from the cytoplasmic side to the extracel
lular side of the cell membrane. Hwang, J. Membrane Bio.,
33, 325-50, (1977). The charge separation resulting from the
absorbed light appears 450 fs after the light incidence, imply
ing the potential for a very high frequency sensor. Wang,
Biosensors and Bioelectronics, 21, 1309-19, (2006).
For engineered applications, bacteriorhodopsin is purified
as membrane patches, known as purple membrane (PM).
Purple membrane is simply a laige cell membrane patch, on
average 500 nm in diameter, which is composed of multiple
bacteriorhodopsin molecules and their associated lipids.
Purple membrane is composed of bacteriorhodopsin and its
associated lipids in a two-dimensional crystal. This structure
provides it a high degree of chemical stability and resistance
to thermal degradation. It is called PM due to its distinct
purple color, which is due to its absorption peak near 570 nm.
Purple membrane has many unique properties that make it
a viable engineering material. Specifically, PM has been
shown to maintain functionality at temperatures up to 80° C.
in water and 140° C. dried. Hampp, Chem. Rev., 100 (5),
1755-76 (2000). In the dried state, as well as the wet state, PM
retains its light absorption properties and photochemical
activity for years.
Quantum dots (QD) are semiconductor particles that have
dimensions on the order of a few nanometers or less. When
compared to other fluorophores, such as fluorescent dyes,
QD’s have higher quantum yields, greater chemical stability,
longer lifetimes, and a greater resistance to photo bleaching.
Jovin, Nature Biotechnology, 21, 32-33 (2003). They are also
tunable based upon dot diameter. Another important charac
teristic is that QDs have a broad absorption range coupled
with narrow emission spectra. The absorption spectrum for
QDs lies primarily in the ultra-violet region while their emis
sion range can be tuned to a very specific wavelength range.
Medintz, Nature Materials, 2, 630-38, (2003). A QD’s emis
sion wavelength is directly dependent upon its diameter, with
a diameter of approximately 2 nm yielding photonic emission
in the 570 nm range.
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light with a wavelength shorter than 570 nm, and comparing
the first and second signals. A difference between the first and
second signals indicates the presence of a targeted chemical
or biological species.
In another embodiment, the invention provides a method
for quantifying an amount of targeted chemical or biological
species in a sample. A bacteriorhodopsin-based sensor with
functionalized fluorophores is exposed to a plurality of cali
brated samples of a chemical or biological species, in the
presence of light with a wavelength shorter than 570 nm, and
the signal from the circuit is recorded for each of the plurality
of calibrated solutions. Using known correlation techniques,
the signal corresponding to each of the plurality of calibrated
samples can be correlated to an amount of targeted chemical
or biological species in each of the plurality of calibrated
samples. Once the bacteriorhodopsin-based sensor with func
tionalized fluorophores is calibrated, an amount of a chemical
or biological species can be quantified in a sample by corre
lating the signal from the circuit to an amount of a chemical or
biological species.
In another embodiment, the invention provides a sensor
array comprising an array of bacteriorhodopsin-based semi
conductor transistor sensors. Membrane layers, containing
bacteriorhodopsin, are arranged to produce responses in the
gates of an array of transistors, the membrane layers may be
adjacent to the gates, or the membrane layers may be adjacent
to adhesion spacer layers, which are adjacent to the gates. The
membranes of the array may be further functionalized by
attaching fluorophores to the membranes, thus allowing the
fluorophores to radiatively or non-radiatively transfer energy
to the membrane when the fluorophores are exposed to light.
By adding multiple functionalities to the fluorophores, the
array may be made simultaneously sensitive to several tar
geted chemical or biological species.
Other aspects of the invention will become apparent by
consideration of the detailed description and accompanying
drawings.

FIG. 12 shows schematic diagrams of wet and dry assem
blies and a graph of the efficiency of non-radiant energy
transfer as a function of distance.
FIG. 13 is a schematic diagram of the protocol for the
construction of a maltose sensor.
FIG. 14 is a schematic diagram of an antibody sensor
according to the invention.
FIG. 15 is a depiction of an array of sensors according to
the invention.
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BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a high-level depiction of an embodiment of the
invention.
FIG. 2 is a representation of a sensor response to a blinking
LED.
FIG. 3 shows the spectral overlap between a fluorophore
emission spectrum and the bacteriorhodopsin absorption
spectrum.
FIG. 4 is a high-level depiction of another embodiment of
the invention.
FIG. 5 is a high-level depiction of another embodiment of
the invention.
FIG. 6 is a schematic diagram of the protocol for producing
oriented purple membrane (PM) films.
FIG. 7 is schematic diagram of completed wet (a) and dry
(b) PM film assemblies.
FIG. 8 is a diagram of an electronic circuit used to measure
charge gradients.
FIG. 9 shows a wet quantum dot-bacteriorhodopsin light
sensor, and a signal from a wet quantum dot-bacteriorhodop
sin light sensor.
FIG. 10 is a signal from a dry quantum dot-bacteriorhodop
sin light sensor.
FIG. 11 compares a signal from a three monolayer bacte
riorhodopsin light sensor to a signal from a three monolayer
bacteriorhodopsin light sensor with attached quantum dots.
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Before any embodiments of the invention are explained in
detail, it is to be understood that the invention is not limited in
its application to the details of construction and the arrange
ment of components set forth in the following description or
illustrated in the following drawings. The invention is capable
of other embodiments and of being practiced or of being
carried out in various ways. Also, it is to be understood that
the phraseology and terminology used herein is for the pur
pose of description and should not be regarded as limiting.
The use of “including,” “comprising,” or “having” and varia
tions thereof herein is meant to encompass the items listed
thereafter and equivalents thereof as well as additional items.
The invention provides, among other things, a bacterior
hodopsin-based sensor that can be used to sense light or
chemical or biological targets of interest.
A high level illustration of a bacteriorhodopsin-based sen
sor 20 is shown in FIG. 1. A layer of purple membrane 21,
comprising bacteriorhodopsin 22 and associated lipids 23 is
deposited on a first electrode 24 that is adjacent to a substrate
25 which provides structural support for the sensor. A second
electrode 26 is placed adjacent to layer of purple membrane
21 opposite first electrode 24. In some embodiments, layer of
purple membrane 21 may be nearby or next to second elec
trode 26 without contacting second electrode 26. In other
embodiments layer of purple membrane 21 may contact sec
ond electrode 26. First electrode 24 and second electrode 26
may be made by sputtering conductive metals or alloys, such
as gold, silver, copper, aluminum, or indium tin oxide, onto a
surface, or directly onto layer of purple membrane 21. Other
methods of constructing first electrode 24 and second elec
trode 26 are known to those of skill in the art. For example,
electrodes may be a conductive wire (e.g., platinum) used in
conjunction with an electrolyte (e.g., potassium chloride).
First electrode 24 and second electrode 26 are operatively
connected to a circuit 30, such that circuit 30 produces a
signal when the chaige gradient between first electrode 24
and second electrode 26 changes. As discussed above, when
bacteriorhodopsin is exposed to light of approximately 570
nm, a proton is pumped from the cytoplasmic side to the
extracellular side of layer of purple membrane 21, resulting in
a change in the charge gradient between first electrode 24 and
second electrode 26. Accordingly, when bacteriorhodopsinbased sensor 20 is exposed to light of approximately 570 nm,
bacteriorhodopsin-based sensor 20 produces a signal.
The response of a bacteriorhodopsin-based sensor 20 is
illustrated in FIG. 2. A yellow-green light emitting diode
(LED) near bacteriorhodopsin-based sensor 20 is cycled on
and off with a 50% duty cycle (upper graph). When the LED
is on, bacteriorhodopsin-based sensor 20 develops a charge
gradient between first electrode 24 and second electrode 26.
The charge gradient results in a measurable signal in circuit
30. The signal increases and then peaks after some time
(lower graph). When the LED is off, the chaige gradient
diminishes through circuit 30, resulting in a falling signal.

US 8,551,407 B2
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Bacteriorhodopsin-based sensor 20 is quite robust, and circuit
3 0 produces a signal that follows the duty cycle of the LED for
hours.
Layer of purple membrane 21 may be “wet” or “dry.”
“Wet” layer of purple membrane 21 implies that the mem
brane is in an aqueous environment. Aqueous environments
are achieved by building pools or trapped spaces into the
sensor. The pools and trapped spaces must be liquid-tight to
avoid shorting-out electronic components.
In other embodiments, it is possible to evaporate the liquid
from the membrane to produce a “dry” layer of purple mem
brane 21. Surprisingly, dry membrane layers maintain their
charge transfer characteristics, and may be stable for months.
Dry membranes allow for easier interfacing to electronic
components. However, producing a functional wet bacterior
hodopsin-based sensor 20 is easier than constructing a dry
bacteriorhodopsin-based sensor 20 because the membrane
layer is more stable in an aqueous environment.
As shown in FIG. 1, bacteriorhodopsin-based sensor 20
may be further functionalized by placing fluorophores 28, in
proximity to layer of purple membrane 21. Fluorophores 28
useful for the invention absorb light with wavelengths shorter
than 570 nm, typically ultraviolet light, and then transfer
some of the energy of the absorbed light to layer of purple
membrane 21 via radiative transfer 27 (i.e., fluorescence).
Thus, absorption of light by fluorophores 28 and emission
within the absorption band of bacteriorhodopsin will result in
a change in charge gradient, and ultimately a signal from
circuit 30. Sensors employing fluorophores will typically use
a shorter wavelength light to activate the sensor, however the
response of the sensor to this light is very similar to that
shown in FIG. 2.
Fluorophores suitable for the invention include, but need
not be limited to, fluorescent dyes, chromophores, and quan
tum dots. Fluorophores suitable for the invention typically
have an emission spectrum overlapping with the absorption
spectrum of bacteriorhodopsin, as shown in FIG. 3. The
absorption spectrum o f bacteriorhodopsin 30 is rather broad
with a peak at approximately 570 nm. In contrast, the emis
sion spectrum of a fluorophore 35 is much narrower. Emis
sion spectrum 35 corresponds to a quantum dot, specifically
chosen for its overlapping emission spectrum. The techniques
for engineering quantum dots to produce a desired emission
spectrum are known to those of ordinary skill in the art.
In some embodiments, the emission spectrum of the fluo
rophores may be altered by the presence of targeted chemical
or biological species. In these embodiments, bacteriorhodop
sin-based sensor 20 may become a sensitive chemical or
biological sensor. For example, fluorophore 28 in proximity
to layer of purple membrane 21 may undergo a conforma
tional change in the presence of a biological species, resulting
in an emission spectrum that no longer overlaps with the
absorption spectrum o f bacteriorhodopsin. Alternatively, for
example, the presence of a chemical species may result in a
change in the electronic structure of fluorophore 28, thereby
shifting the emission spectrum of fluorophore 28 from the
peak of the bacteriorhodopsin absorption spectrum. When a
binding event causes a shift in the emission spectrum of
fluorophore 28, the bacteriorhodopsin will not pump as many
protons across the membrane gradient. The decrease in pro
ton pumping diminishes the charge gradient between first
electrode 24 and second electrode 26, thus the signal from
circuit 30 diminishes. By monitoring for signal drops, it is
possible to detect a wide range of binding events with extreme
sensitivity.
In embodiments where fluorophores 28 are quantum dots,
it is possible to additionally functionalize the quantum dots

with receptors 29 that bind targeted chemical or biological
species. Targeted biological species may include, but need not
be limited to, antibodies, antigens, proteins, nucleic acids,
enzymes, and lipids. Targeted chemical species may include,
but need not be limited to, antigens, hormones, small mol
ecules, drugs, drug candidates, alkanes, alkenes, alkynes, and
aromatic species, as well as substituted alkanes, alkenes,
alkynes, and aromatic species. For example, a quantum dot
may be functionalized with an antibody. In the presence of
light, and in the absence of an antigen that binds that antibody,
the quantum dots emit light that overlaps the absorption spec
trum of bacteriorhodopsin, producing a signal from circuit
30. When the antibody binds an antigen, however, the emis
sion spectrum of the quantum dot shifts, resulting in a change
in the signal of circuit 30. In other embodiments, the emission
of fluorophore 28 may be quenched completely, resulting in
no signal.
The invention is not limited to the use of antibodies as
receptors, however. For example, quantum dots may also be
functionalized with the substrate recognition region of an
enzyme, or with a binding protein, or with a nucleic acid
aptamer. Receptors may be adapted from known biological
structures or new receptors may be specifically developed for
a sensor of the invention via combinatorial screening or com
puter-aided design.
Receptors need not be incorporated into, or attached to, the
fluorophore, however. The invention also includes receptors
incorporated into linker molecules or linkages (discussed
below). Such receptors may be sensitive to antibodies, anti
gens, proteins, nucleic acids, enzymes, lipids, hormones,
small molecules, drugs, drug candidates, alkanes, alkenes,
alkynes, or aromatic species, as well as substituted alkanes,
alkenes, alkynes, or aromatic species Receptors may be addi
tionally incorporated into the bacteriorhodopsin or lipids of
the purple membrane using known techniques of genetic
engineering and chemical synthesis. In view of this disclo
sure, one of skill in the art of molecular biology should be able
to develop a number of sensors specific to the particular
chemical or biological species of interest.
In embodiments where fluorophores 28 are quantum dots,
it may be additionally beneficial to use linker molecules to
keep fluorophores 28 in proximity to layer of purple mem
brane 21 so that light emitted from fluorophores 28 is cap
tured by the bacteriorhodopsin in layer of purple membrane
21. Linker molecules may include, but need not be limited to,
long-chain organic molecules comprising at least one carboncarbon double bond. Such long-chain hydrocarbons may
include unsaturated fats and/or surfactants. Linker molecules
may also comprise oligomers of organic molecules or nucleic
acids. In some embodiments, the linker molecules may be
streptavidin-biotin constructs. In some embodiments, the
linker molecules may be 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide hydrochloride (EDC). Linker molecules addi
tionally may be functionalized with receptors such that the
linker molecules will undergo conformational changes result
ing in a change in distance between layer of purple membrane
21 and fluorophores 28.
The principles of the invention may be used to produce
bacteriorhodopsin-based transistor sensors. A generalized
bacteriorhodopsin-based transistor sensor 40 is shown in
FIG. 4. Rather than using two electrodes and measuring a
change in charge gradient across layer of purple membrane
21, transistor sensor 40 measures variations in the charge
density of the cytoplasmic side of layer of purple membrane
21 via a gate 41 of a simple semiconductor field effect tran
sistor (FET).
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One embodiment is represented in FIG. 4. The FET is
comprised of gate 41, source 42, drain 43, and body 44.
Similar to FIG. 1, layer of purple membrane 21 may be
directly deposited on the metal surface of gate 41. For tran
sistor sensors 40, layer of purple membrane 21 is typically 5
dried once it is attached to gate 41. The surface area of layer
of purple membrane 21 in transistor sensor 40 is typically less
than about 10 pmxlO pm, preferably less than about 5 pmx5
pm. The FET is provided with an external power source (not
shown). Source 42 and drain 43 are attached to a circuit 45, 10
allowing the potential at gate 41 to be measured as a function
of time. Circuit 45 may comprise an oscilloscope, a personal
digital assistant, or a personal computer, for example. When
transistor sensor 40 is exposed to light 46 from an LED 47, the
change in charge density at gate 41 will result in a signal from 15
circuit 45. Modulating the output of LED 47 will result in a
modulated signal, as shown in FIG. 2.
FETs suitable for the bacteriorhodopsin-based transistor
sensors 40 of the invention may be created using techniques
known to those of average skill in the art. Additionally one of 20
skill in the art will be capable of fabricating many FETs on a
singular substrate and wiring and powering the FETs indi
vidually to create arrays of FETs. One of average skill in the
art will also be capable of protecting the subcomponents of
the FETs (e.g., withresins) from the solutions used to perform 25
additional processing steps, including the deposition of layers
of purple membrane.
In another embodiment, monolayers of purple membrane
may be deposited atop the gate of an FET with an exposed
metal gate using ionic self-assembled monolayer films. 30
Monolayer deposition may be accomplished by rinsing gate
41 in a strong base to render a net negative charge on the gate,
then dipping gate 41 into a solution of poly(dimethyldiallylammonium) chloride to produce a surface of positive charge,
and then dipping gate 41 into a solution of purple membrane. 35
Typically, a deposition time of 5 minutes will yield a single
monolayer of purple membrane, i.e., bacteriorhodopsin pro
teins arranged in a singular lipid bi-layer, as depicted in FIG.
4. Typically, a slide strainer is used for the dip steps, however
other methods of depositing films are known to those of 40
average skill the relevant art. In this embodiment, the poly
(dimethyldiallylammonium) chloride acts as an adhesion
spacer layer. Other adhesion spacer layer species may be
substituted for poly(dimethyldiallylammonium) chloride.
In other embodiments, monolayers of purple membrane 45
may be deposited without an adhesion spacer layer by
directly dipping the gate into a prepared film of purple mem
brane, e.g., using Langmuir-Blodgett (L-B) techniques. After
building up the desired number of monolayers using L-B, it is
then possible to functionalize the purple membrane layers 50
with additional L-B films, which may optionally contain fluorophores and/or receptors.
While one monolayer of purple membrane will produce
functional sensors, in other embodiments it may be beneficial
to deposit multiple monolayers of purple membrane. Mul 55
tiple monolayers may be achieved through iterative dipping in
poly(dimethyldiallylammonium) chloride and purple mem
brane solutions, or through iterative dipping in an L-B trough
without the poly (dimethyldiallylammonium). Bacterior
hodopsin-based transistor sensors 40 of the invention will 60
typically have less than 10 monolayers of purple membrane,
or less than 5 monolayers of purple membrane, more typically
only 2 or 1 monolayers of purple membrane.
Using alternative adhesion spacer layer species, such as
polystyrene sulfonate, it is possible to deposit the extracellu 65
lar side of layer of purple membrane 21 to gate 41 to produce
transistor sensor 40. Attaching the extracellular side of layer
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of purple membrane 21 to gate 41 will result in a different bias
for gate 41. Depending upon the application for transistor
sensor 40, a reversed gate 41 bias may be beneficial.
Layer of purple membrane 21 in transistor sensor 40 may
be functionalized with fluorophores 28, as shown in FIG. 5 to
create a chemical/biological transistor sensor 50. Like tran
sistor sensor 40, chemical/biological transistor sensor 50
comprises layer of purple membrane 21, a FET comprising
gate 41, source 42, drain 43, body 44, and circuit 45 for
measuring the potential at gate 41. Chemical/biological tran
sistor sensor 50 further comprises fluorophores 28 attached to
layer of purple membrane 21. Fluorophores 28 may be
attached by depositing additional layers of poly(dimethyldiallylammonium) chloride atop the monolayer(s) of purple
membrane, and then dipping the poly(dimethyldiallylammonium) chloride-coated structure in fluorophores 28 having a
negative charge. Fluorophores 28 may also be attached with
linker molecules such as linkages 51. When chemical/bio
logical transistor sensor 50 is exposed to shorter wavelength
light 54, from light source 56, fluorophores 28 will absorb
shorter wavelength light 54, and re-emit longer wavelength
light (not shown) that coincides with absorption spectrum of
bacteriorhodopsin 30, shown in FIG. 3. Shorter wavelengths
of light, suitable for activating sensors of the invention, typi
cally comprise light of wavelengths shorter than 570 nm.
Linkages 51 and or adhesion spacer layers are necessary to
keep fluorophores 28 in proximity to layer of purple mem
brane 21 so that light emitted from fluorophores 28 is cap
tured by the bacteriorhodopsin in layer of purple membrane
21. Linkages may include, but need not be limited to, longchain organic molecules comprising at least one carbon-car
bon double bond. Such long-chain hydrocarbons may include
unsaturated fats and/or surfactants. Linkages may also com
prise oligomers of organic molecules or nucleic acids. In
some embodiments, the linkages may comprise streptavidinbiotin constructs. Linkages 51 may also comprise l-ethyl-3(3-dimethylaminopropyl)
carbodiimide
hydrochloride
(EDC). Linkages 51 may additionally be functionalized with
receptors such that linkages 51 will undergo conformational
changes resulting in a change in distance between layer of
purple membrane 21 and fluorophores 28.
In some embodiments, linkages 51 may be directly bound
to layer of purple membrane 21. Direct binding is possible by
using streptavidin-biotin constructs, for example. First, bac
teriorhodopsin is biotinylated by mixing biotin into a suspen
sion of purple membrane fragments in 0.1 M sodium bicar
bonate buffer (pH of about 8.5). During mixing, the biotin
attaches to lysine residue 129 in the bacteriorhodopsin pro
tein. Next, the purple membrane fragments can be reas
sembled into layer of purple membrane 21 by using mem
brane assembly techniques, including, but not limited to,
electrophoretic sedimentation. Then fluorophore 28 is func
tionalized with streptavidin using techniques known to those
of average skill in the art. Finally, when streptavidin-functionalized fluorophores 28 are deposited onto layer of purple
membrane 21, the streptavidin binds to the biotin functional
ized bacteriorhodopsin, resulting in linkage 51 between layer
of purple membrane 21 and fluorophore 28.
In addition to keeping fluorophores 28 bound to layer of
purple membrane 21, it is preferably that linkages 51 main
tain a specific distance between fluorophores 28 and the bac
teriorhodopsin in layer o f purple membrane 21 to maximize
the signal produced as a result of a change in distance between
fluorophore 28 and layer of purple membrane 21. As has been
well-described (Lakowicz, Principles o f Fluorescence Spec
troscopy (1999)) the efficiency of non-radiative energy trans
fer (Forster eneigy transfer) is a function of the distance
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between fluorophore 28 and the bacteriorhodopsin in layer of
purple membrane 21. This phenomenon is known broadly as
Fluorescence Resonance Energy Transfer (FRET). The rela
tionship between distance and non-radiative transfer is given
by

In the presence of shorter wavelength light 54, and in the
absence of an antigen that binds to the antibody, the quantum
dots emit light that overlaps the absorption spectrum of bac
teriorhodopsin, producing a signal from circuit 45. When the
antibody binds an antigen, however, the emission spectrum of
the quantum dot shifts, resulting in a change in the signal of
circuit 45.
The relationship between distance and efficiency of nonradiative transfer provides another mechanism for activating
chemical/biological transistor sensor 50. Linkages 51 may be
engineered such that linkages 51 have receptors for targeted
chemical or biological species. In the presence of the targeted
chemical or biological species, linkages 51 undergo a confor
mational change, thus bringing fluorophores 28 closer to
layer of purple membrane 21. When fluorophores 28 move
closer to layer of purple membrane 21, the amount of nonradiative energy transfer increases, resulting in a smaller
charge density at gate 41, and a decreased signal from circuit
45. It is also possible that targeted chemical and/or biological
binding events will result in the severance or detachment of
linkages 51. The severance or detachment of linkages 51 will
also result in a diminished signal from circuit 45.
Methods of using the sensors of the invention for the detec
tion and quantification of targeted chemical or biological
species are straightforward. In embodiments where the goal is
merely to detect targeted chemical or biological species, it
may be sufficient to merely contact the sensor with a sample,
in the presence of shorter wavelength light, and observe the
signal for a change. This method may be beneficial for toxin
detection, for example, wherein any presence of the toxin is
cause for alarm. Samples may include, but need not be limited
to, bodily fluids, municipal water, air, process fluids, combus
tion effluent, groundwater, fuels, and foods.
In other embodiments where the goal is to quantify an
amount of targeted chemical or biological species, it may be
necessary to calibrate the sensor ahead of time using calibra
tion samples having known quantities of targeted chemical or
biological species. By presenting a plurality of samples with
known amounts of targeted chemical or biological species
and recording the signal for each calibrated sample, it is
possible to construct a correlation that can be used to quantify
an amount of targeted chemical or biological species in a
sample. For example, five calibration samples may be pre
sented to the sensor, resulting in five different signals. The
signals of the five calibration samples may be correlated to
known amounts of targeted chemical or biological species
using a least-squares fitting function. The correlation result
ing from the least-squares fitting function can be used to
quantify amounts of targeted chemical or biological species
in samples based upon the signal. Other methods of correlat
ing signal to amount are known to those of skill in the art.

i} 06=( 8.8X1023 mol)(K2)(nD4)(<S>D)(J(X)))

(I)

where R0 is the distance at which 50% of the donor’s energy
is transferred non-radiatively, K is the dipole orientation fac
tor, r\D is the refractive index of the medium, <bD is the quan
tum yield of the donor, and J is the normalization overlap
integral between the donor and acceptor at the specific wave
length X. Thus the efficiency, E, of the non-radiative energy
transfer is indicative of R, the distance between fluorophore
28 and the bacteriorhodopsin in layer of purple membrane 21.
The efficiency of the non-radiative energy transfer is
described by equation 11.

Rf
E = ____0__
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Because of conservation of energy, an increase in the effi
ciency of non-radiative energy transfer results in a consumate
decrease in the efficiency of radiative energy transfer.
Because bacteriorhodopsin only produces a charge gradient
in the event of radiative energy transfer (i.e. fluorophore fluo
rescence), a decrease in distance between fluorophores 28 and
the bacteriorhodopsin in layer of purple membrane 21, should
result in a decreased signal measured by circuit 45.
The relationship between non-radiative eneigy transfer and
distance produces a characteristic curve, like the one shown in
FIG. 12C. (The curve in FIG. 12C is for the 565 nm emissioncenter quantum dot and bacteriorhodopsin system exempli
fied below.) As can be seen in FIG. 12C, there is an inflexion
point at approximately 7.6 nm of separation between the
quantum dot and the retinal molecule in the bacteriorhodop
sin. Thus, at 7.6 nm o f separation, small changes in distance
result in dramatic changes in non-radiative transfer. Typi
cally, sensors of the invention are engineered to have the
separation between fluorophore 28 and layer of purple mem
brane 21 at approximately the inflexion point of the curve in
the absence of targeted chemical or biological species.
Like the embodiments described above with respect to
FIG. 1, the emission spectrum of fluorophores 28 may be
altered by the presence of a chemical or biological species.
For example, fluorophore 28 linked to layer of purple mem
brane 21 may undergo a conformational change in the pres
ence of a biological species, resulting in an emission spec
trum that no longer overlaps with absorption spectrum of
bacteriorhodopsin 30. Alternatively, for example, the pres
ence of a chemical species may result in a change in the
electronic structure of fluorophore 28, thereby shifting emis
sion spectrum 35 of fluorophore 28 from the peak of the
bacteriorhodopsin absorption spectrum. Similar to the
embodiments described with respect to FIG. 1, when a bind
ing event causes a shift in the emission spectrum of fluoro
phore 28, the bacteriorhodopsin will not pump as many pro
tons across the membrane gradient. The decrease in proton
pumping diminishes the charge density at gate 41, thus the
signal from circuit 45 diminishes. In other embodiments, the
emission of fluorophore 28 may be quenched completely.
In embodiments where fluorophores 28 are quantum dots,
it is possible to additionally functionalize the quantum dots
with receptors 29 that bind targeted chemical or biological
species. Receptors 29 may comprise antibodies, for example.
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The following non-limiting examples further illustrate the
sensors of the invention.
Example 1

60

65

Preparation of Oriented Purple Membrane
The process of preparing and purifying bacteriorhodopsin
for engineered applications has been described (Stuart,
Preparation, purification and modification of bacteriorhodop
sin for use in protein-based optical devices). In brief, the
Halobacterium salinarium cells were grown at 40° C. in a
basal salts medium containing bacteriological peptone. Once
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grown to a desired density, the cells were collected by cen
trifugation at 17,700 g for 10 minutes. The collected cells
were then lysed through the addition of deionized water. The
released nucleic acids were digested with 1-3 Units/ml, final
solution volume, of DNase I. The laiger cell debris was col
lected through centrifugation at 3,000 g for 5 minutes. Purple
membrane (bacteriorhodopsin and associated lipids)
remained in the supernatant and was separated from the red
membrane by centrifugation at 105,000 g for 30 minutes. The
purple membrane was pelleted in this centrifugation step,
which was repeated until the supernatant was clear. For addi
tional purification, the purple membrane was passed over a
linear sucrose gradient. The purity of the resulting bacterior
hodopsin preparation was evaluated by sodium dodecyl sul
fate-polyacrylamide gel electrophoresis (SDS-PAGE) on a
12% Bis-Tris gel.
Purple membrane layer for a sensor was created using
electrophoretic sedimentation (EPS) as shown in FIG. 6. This
method provides a layer of purple membrane comprising
highly-orientated bacteriorhodopsin, e.g., the cytoplasmic
ends of the bacteriorhodopsin are identically-oriented. A fix
ture 60 was constructed to hold substrate 25 (glass slide) with
first electrode 24, and a brass electrode 62 apart, with a
separation distance of approximately 1 mm. The distance of
separation is not critical, and the EPS will work with larger
and smaller separations. First electrode 24 (positive elec
trode) is a sputtered layer of optically transparent and elec
trically conductive indium tin oxide (ITO) on substrate 25.
The dimensions of the slide (25) were 5 mmxlO mm and
electrode 24 had a sheet resistance of 5-10Q. Thirty pi of
suspension 64 of 15 mg/ml purple membrane in distilled/
deionized water (ddl) water was pipetted on top of first elec
trode 24 and substrate 25. The brass electrode 62 (negative
electrode) was placed on top with 1 mm spacing between the
electrodes. An electric field of 40 V/cm was applied between
the electrodes for 1 minute, as depicted in FIG. 6. It was
possible to visually observe layer of purple membrane 21
deposit out of suspension 64 and attach to first electrode 24
while the electric field was being applied.
Following the 1 minute exposure to the electric field, the
top brass electrode 62 was removed and the excess water was
pipetted off layer of purple membrane 21. First electrode 24
with attached layer of purple membrane 21 was then rinsed
for 10 seconds in a beaker of distilled/deionized water to
remove any weakly attached purple membrane. First elec
trode 24 with attached layer of purple membrane 21 was then
stored in a humidity chamber for 24 hours to dry. Flumidity in
the chamber was maintained at -52% through the use of a
magnesium nitrate salt solution. The dimensions of substrate
25 with attached first electrode 24 with attached layer of
purple membrane 21 was approximately 5 mmx5 mm with a
thickness of layer of purple membrane 21 of approximately
20 pm measured with an interferometric microscope.
For applications which require a wet layer (aqueous sus
pension) of layer of purple membrane 21, a glass slide 73 with
second electrode 26 (also indium-tin-oxide) may be placed
atop a prior assembly of substrate 25, electrode 24, and layer
of purple membrane 21 after rinsing (above) but before dry
ing (above), as shown in FIG. 7 (a). In order to maintain the
aqueous environment, it is necessary to add a spacer 74
around the perimeter of the layer of layer of purple membrane
21 in order to keep layer of purple membrane 21 wet. Spacer
74 may be, for example, a rubber O-ring. The resulting con
struct is hereafter a wet assembly 72.
Alternatively, some applications require dry layer of purple
membrane 21. For these applications, substrate 25 with
attached first electrode 24 with attached layer of purple mem

brane 21 can be dried as described above and shown in FIG.
6, and the resulting layer of purple membrane 21 sputtered
with a layer of gold to create second electrode 26, to create the
structure shown in FIG. 7 (b). The resulting construct is
hereafter a dry assembly 76.
A representative circuit 30 capable of producing a signal in
response to a charge gradient across layer of purple mem
brane 21 is shown in FIG. 8. Circuit 30 can measure a change
in voltage (AV) between first electrode 24 and second elec
trode 26 in either wet assembly 72 or dry assembly, and
amplify the AV for recording by an oscilloscope or computer.
Circuit 30 comprises an operational amplifier, resistors, and
capacitors as necessary to reduce noise and achieve the
desired amplification of the AV between first electrode 24 and
second electrode 26. Electronic circuit 30 shown in FIG. 8
acts as a xlO amplifier, however other amplifications are
possible and the modifications necessary to achieve alternate
amplifications are known to those of skill in the art. For the
experiments shown herein, bacteriorhodopsin-based sensor
20 and circuit 30 were placed inside a Faraday cage to reduce
RF noise. Circuit 30 was powered by a triple output voltage
supply (F1P 6237A, Agilent Technologies, Santa Clara,
Calif.). The output signal from circuit 30, Vou„ was run
through a low-frequency noise filter (Krohn-Flite 3364,
Krohn-Flite, Brockton, Mass.). After filtering, the condi
tioned signal is sent into a 60 MFlz, 200 MSa/s oscilloscope
(Agilent 54621D, Agilent Technologies, Santa Clara, Calif.)
for analysis.
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Quantum dots (Evident Technologies, Troy, N.Y.) having
an emission band centered at 565 nm were chosen to maxi
mize the overlap between quantum dot fluorescence spectrum
35 and bacteriorhodopsin absorption spectrum 30. This over
lap is depicted in FIG. 3.
FIG. 9A shows a completed quantum dot, bacteriorhodop
sin-based optical sensor 90 with circuit 3 0 removed. A well 91
was formed by placing a rubber gasket 92 around the perim
eter of the back side of glass slide 73 of wet assembly 72. A 40
pL volume of 63 nmol/L quantum dot suspension 93 was
applied added to well 91. A 310 nm light-emitting diode
(LED) 94 was arranged at an angle so that LED 94 would
illuminate the layer of quantum dots with UV light 95, with
minimal direct exposure o f the bacteriorhodopsin in layer of
purple membrane 21. With LED 94 flashing at approximately
4 Flz, the quantum dots were visibly activated, and their
photonic emission resulted in a AV and corresponding peaks
99, as shown in FIG. 9B. The periodic peaks 99 generated
from bacteriorhodopsin-based optical sensor 90 directly cor
related to the flashing of the LED 94.
Example 3
Addition of Quantum Dot Layer to Dry Assembly

60

65

Dry assembly 76 was prepared as described above. A 63
nmol/L suspension of quantum dots was pipetted upon the
second electrode 26, and the quantum dot suspension is
allowed to dry. A semiconductor parameter analyzer was used
in lieu of the low-frequency noise filter and oscilloscope in
order to increase sensitivity.
Dry assembly 76 with quantum dots, and without quantum
dots, were compared to judge the signal boost gained from the
addition of the quantum dots. As in previous examples, the
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sensors were exposed to flashing LEDs. FIG. 10 shows a
comparison of the UV-light sensitivity of dry assembly 76
before 102, and after 103, the deposition of the quantum dots.
As can be seen from FIG. 10, there are some small peaks 106
attributable to the flashing LED before 102 the quantum dots
are deposited. However, the signal peaks 108 increased nearly
an order of magnitude once the quantum dots were deposited.
Comparing the signals of “wet” bacteriorhodopsin-based
optical sensor 90 (FIGS. 9A, B) to “dry” bacteriorhodopsinbased optical sensor (FIG. 10), it is clear that the wet sensor
has a much larger signal output than the dry sensor for similar
UV-illumination events. This is not surprising, given the dif
ference in the spacing between layer of purple membrane 21
and the quantum dot layers in the wet and dry sensors, respec
tively. As seen in FIG. 12A, the spacing between layer of
purple membrane 21 and quantum dots in the “wet” sensor is
approximately 1 mm, corresponding to the thickness of glass
slide 73. As seen in FIG. 12B, the spacing between layer of
purple membrane 21 and quantum dots in the dry sensor is
approximately 4 nm, the thickness of second electrode 26.
Again, because of the relationship between distance and nonradiative transfer, illustrated in FIG. 12C, it is expected that
signal due to radiative energy transfer would be smaller in the
“dry” sensor where the quantum dots and the bacteriorhodopsin are close together.

tin oxide (ITO) electrode atop a substrate. In an iterative
fashion, a layer of poly(dimethyldiallylammonium) was
deposited upon the first monolayer of purple membrane, then
a second layer of purple membrane was deposited upon the
layer of poly(dimethyldiallylammonium), then a layer of
poly(dimethyldiallylammonium) was deposited upon the
second monolayer of purple membrane, then a third layer of
purple membrane was deposited upon the layer of poly(dimethyldiallylammonium). The third monolayer of purple
membrane was biotinylated prior to deposition by mixing
biotin into a suspension of purple membrane fragments in 0.1
M sodium bicarbonate buffer (pH of about 8.5). After the
purple membrane monolayers were deposited, a platinum
wire was placed in proximity to the purple membrane monolayers, and two drops of 0.1 M KC1 were added to assure
electrical contact. The ITO electrode and platinum wire were
then attached to a xlO preamp and oscilloscope. When a
Xenon lamp was switched on, a peak was visible on the
oscilloscope, which decayed away in approximately 2 sec
onds. When the Xenon lamp was switched off, a negative
peak was visible. See FIG. 11, “no QD.”
The platinum wire was then removed, the KC1 pipetted
away, and the purple membrane layers washed with D1 water.
The assembly was then incubated with 0.5 nmol/ml streptavidin-coated quantum dots (595 nm emission center) for 15
minutes. After the incubation period the assembly was rinsed
for 2 minutes in D1 water to remove any unbound quantum
dots. The platinum wire was replaced, two drops of KC1
solution were added, and the sensor reattached to the preamp
and oscilloscope. As can be seen in FIG. 11 the resulting
sensor had a similar response to the Xenon light, however the
amplitude of the response was greater. See FIG. 11, “QD.”
The response was greater because the quantum dots allowed
the bacteriorhodopsin in the purple membrane to use a greater
number of the photons emitted from Xenon light spectrum.
That is, some of the photons that were too energetic to be
captured by the bacteriorhodopsin were transferred to the
bacteriorhodopsin via the quantum dots.

Example 4
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Preparation of Thin Oriented Purple Membrane
The fabrication methods described in Example 1 produce
oriented purple membranes on the order of 20 pm thick.
However, in order to take advantage of changes in radiative
versus non-radiative energy transfer, it is necessary to pro
duce oriented purple membranes on the order of tens of
nanometers thick, preferably one monolayer of purple mem
brane (e.g., comprising only bacteriorhodopsin and a singular
lipid bilayer). As in Example 1, Halobacterium salinarium
cells were grown at 40° C. in a basal salts medium containing
bacteriological peptone. Once grown to a desired density, the
cells were collected by centrifugation at 17,700 g for 10
minutes. The collected cells were then lysed through the
addition of deionized water. The released nucleic acids were
digested with 1-3 Units/ml, final solution volume, of DNase I.
The larger cell debris was collected through centrifugation at
3,000 g for 5 minutes. Purple membrane (bacteriorhodopsin
and associated lipids) remained in the supernatant and was
separated from the red membrane by centrifugation at 105,
000 g for 30 minutes. The purple membrane was pelleted in
this centrifugation step, which was repeated until the super
natant was clear. For additional purification, the purple mem
brane was passed over a linear sucrose gradient. The purple
membrane was then suspending in distilled deionized water.
An electrode of indium tin oxide was deposited on a sub
strate. The substrate with electrode was coated with poly
(dimethyldiallylammonium) chloride using a LangmuirBlodgett trough, to produce a surface-charged electrode
substrate assembly. When the surface-charged electrode
substrate assembly was soaked in a purple membrane
suspension for approximately 5 minutes, a monolayer of ori
ented purple membrane was deposited upon the electrode.
When allowed to dry under controlled humidity, the resultant
monolayer of oriented purple membrane was quite robust.
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Example 5
Thin Oriented Purple Membrane—Quantum Dot
Light Sensor
65

Using the techniques described in Example 4, a monolayer
of oriented purple membrane was deposited upon an indium

A maltose sensor according to the invention is depicted in
FIG. 13. The maltose sensor will begin with a dry assembly
such as that described in Example 1. Using biotin-streptavidin linkages, a layer of quantum dots 121 will be added to the
gold electrode of dry assembly 76. The distance R, between
the quantum dots 128 and layer of purple membrane 21 will
be selectively fixed at approximately 8 nm by linking quan
tum dots 121 directly to second electrode 26, as seen in FIG.
13A.An8nmseparationbetween quantum dots 121 andlayer
of purple membrane 21 will result in the greatest sensitivity of
the sensor to changes in distance due to binding of chemical
species.
As shown in FIG. 13 A, the dry sensor will be prepared with
a second electrode 26 of sputtered gold. The sputtered gold
surface will be biotinylated with biotin 122 using known
techniques. Quantum dots 121 will be coated with a single
monolayer of streptavidin 124. When biotinylated second
electrode 26 is exposed to streptavidin-coated quantum dots
121, the quantum dots will self-assemble at a distance
approximately 8 nm from layer of purple membrane 21. The
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quantum dot-linked dry assembly 126 will then be washed
with distilled deionized water to remove the excess quantum
dots 121.
As shown in FIG. 9B-D, quantum dot-linked dry assembly
126 becomes the basis for a maltose sensor. Quantum dotlinked dry assembly 126 will be washed with biotin coated
maltose-binding protein 127 (FIG. 13B). The assembly
shown in FIG. 13B will give a consistent signal upon illumi
nation with UV-light, as shown previously in FIGS. 9B and
10, because the distance between quantum dots 121 and layer
of purple membrane 21 is approximately 8 nm. Fiowever,
when a (3-CD-QSY9 dark quencher 128 is introduced to mal
tose binding protein 127, dark quencher 128 occupies the
binding site that would otherwise be taken by maltose. (See
FIG. 13C.) Because dark quencher 128 essentially shortcircuits the radiative energy transfer pathway, there is no
signal from the sensor. Upon introduction of maltose 129,
dark quencher 128 is displaced, re-establishing the radiative
energy transfer pathway for quantum dots 121, as shown in
FIG. 13D. Once the radiative energy transfer pathway is
re-established, a signal will be produced by the sensor. Thus,
the sensor in FIG. 13 is silent until maltose is present, at which
point the sensor produces a signal.

exposed and activated, so that the gates in that region will
receive one or more monolayers of oriented purple mem
brane. A solution of quantum dots with functionalize linkages
will then be introduced to the sensor, resulting in 144 FET
sensors similar to those described in FIG. 5 and FIG. 14. After
the first group of 144 FETs has been transformed into chemi
cal sensors, the second group of FETs will be transformed.
Fiowever, this group will have functionalized linkages that are
specific to a different chemical target. In an iterative fashion,
the third and fourth FET groups are converted to chemical
sensors. The finished chemical sensor array 140 will have 576
total chemical sensors. The finished chemical sensor array
140 will be sensitive to four different chemical species.
Thus, the invention provides, among other things, a bacteriorhodopsin-based sensor capable of detecting chemical and
or biological species. Various features and advantages of the
invention are set forth in the following claims.
We claim:
1. A sensor comprising:
a substrate;
a first electrode in contact with the substrate;
a membrane adjacent to the first electrode, wherein the
membrane comprises bacteriorhodopsin;
a second electrode adjacent to the membrane, wherein
charge is transferred between the first and second elec
trodes when the membrane is exposed to visible light;
and
a circuit operatively connected to the first and second elec
trodes, wherein the circuit produces a signal when
charge is transferred between the first and second elec
trodes;
wherein the sensor comprises a fluorophore adjacent to the
second electrode and the fluorophore transfers energy to
the membrane when the fluorophore is exposed to light
with a wavelength shorter than 570 nm.
2. The sensor of claim 1, wherein the membrane is purple
membrane.
3. The sensor of claim 2, wherein the purple membrane is
wet.
4. The sensor of claim 2, wherein the purple membrane is
dry.
5. The sensor of claim 1, wherein the fluorophore is
attached to the membrane with a linker molecule.
6. The sensor of claim 5, wherein the linker molecule is a
biotin-streptavidin construct.
7. The sensor of claim 1, wherein the energy transfer
between the fluorophore and the membrane comprises a
radiative process.
8. The sensor of claim 1, wherein the energy transfer
between the fluorophore and the membrane comprises a nonradiative process.
9. The sensor of claim 1, wherein the fluorophore is a
quantum dot.
10. The sensor of claim 9, wherein the quantum dot is
functionalized.
11. The sensor of claim 10, wherein the functionalized
quantum dots are functionalized with receptors that bind tar
geted chemical or biological species.
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Antibody Sensor
An antibody sensor according to the invention is described
in FIG. 14. Instead of functionalizing quantum dots 121 as in
FIG. 13, linkages 133 are functionalized with antigens 135
specific to antibodies 137 of interest. Absent antibody 137,
quantum dots 121 are maintained 8 nm from layer of purple
membrane 21 because of linkages 133. Again, as shown in
FIG. 12C, when quantum dots 121 and layer of purple mem
brane 21 are separated by more than 8 nm, there is little
non-radiative transfer. Thus, circuit 30 (not shown) produces
large signals in the absence of non-radiative transfer. Fiow
ever, when antibody 137 is introduced, antibody 137 will
cause a conformational change in linkage 133, bringing quan
tum dots 121 closer to layer of purple membrane 21. As
quantum dots 121 move closer to layer o f purple membrane
21, the amount of non-radiative transfer increases, and there
fore, the signal decreases. Thus, the sensor in FIG. 14 will
produce a signal until the introduction of antibody 137, at
which time the signal will decrease.
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Example 8
Chemical Sensor Array
A chemical sensor array 140 will be constructed from a
field of FETs prepared on a silicon chip using known semi
conductor fabrication techniques. Chemical sensor array 140
is depicted in FIG. 15. Chemical sensor array 140 will have
four groups 142 of 144 FETs. (Each FET 143 is a separate
source, drain, gate, body arrangement as shown in FIGS. 4 &
5.) Using iterative photolithographic techniques, the gates of
the FETs 143 in each of the four separate groups 142 will be
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